Ritonavir Tablet
Product Images NDC 65162-061

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ritonavir (NDC 65162-061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bsa (Ritonavir Tablets Usp 1)

An illustration showing the formula to calculate Body Surface Area (BSA) in square meters. The formula depicts BSA as the square root of height in centimeters multiplied by weight in kilograms, divided by 3600.*

FDA Label Image

Description Formula (Ritonavir Tablets Usp 2)

Chemical structure diagram of Ritonavir, showing its molecular configuration including rings and functional groups as part of the active ingredient's chemical composition.*

FDA Label Image

60ct Label (Ritonavir Tablets Usp 3)

Label for Ritonavir Tablets, USP 100 mg oral tablets by Amneal Pharmaceuticals LLC. The label shows the NDC 65162-061, package size of 60 tablets, and includes storage instructions to keep at or below 30°C, with warnings about exposure to heat and humidity. It features a caution note for pharmacists and patients about the tablet formulation and medication interactions and displays a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.